Chronic kidney disease (CKD) affects more than 25 million American adults. Kidney failure leads to the retention of metabolic waste products that functionally disrupt multiple tissues, including skeletal muscle. CKD patients have markedly reduced skeletal muscle mass and strength, which adversely impacts ambulation, functional independence, and quality of life. Previous evidence and our preliminary data suggest that mitochondrial dysfunction may be a central mechanism of skeletal muscle impairment in CKD. However, previous studies lack comprehensive assessments of key functional mitochondrial characteristics, may be confounded by other conditions inherent to CKD, and lack correlation with real-world physical performance measures. The goal of this application is to directly measure functional muscle mitochondrial properties in a broad cohort of CKD patients. We will utilize non-invasive magnetic resonance imaging and optimal spectroscopy tools to quantify muscle mitochondrial characteristics and will evaluate their associations with clinically relevant physical performance measures. We will then conduct a pilot trial to determine whether an aerobic and resistance training program plus coenzyme Q10 can modify mitochondrial functional properties in CKD. 1

Public Health Relevance

The loss of skeletal muscle mass and strength are common complications of chronic kidney disease that directly impact functional independence. Mitochondrial dysfunction may be a major cause of muscle impairment in chronic kidney disease patients. In this grant we will directly measure skeletal muscle mitochondrial function using innovative imaging tools, determine associations with real-world physical performance, and test whether mitochondrial functional properties can be improved by exercise and co- enzyme Q10 therapies. 1

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK101509-02
Application #
9091525
Study Section
Kidney, Nutrition, Obesity and Diabetes (KNOD)
Program Officer
Flessner, Michael Francis
Project Start
2015-06-20
Project End
2019-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Roshanravan, Baback; Zelnick, Leila R; Djucovic, Daniel et al. (2018) Chronic kidney disease attenuates the plasma metabolome response to insulin. JCI Insight 3:
Roshanravan, Baback; Patel, Kushang V; Fried, Linda F et al. (2017) Association of Muscle Endurance, Fatigability, and Strength With Functional Limitation and Mortality in the Health Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 72:284-291
Roshanravan, Baback; Kestenbaum, Bryan; Gamboa, Jorge et al. (2016) CKD and Muscle Mitochondrial Energetics. Am J Kidney Dis 68:658-659